Amlodipine and Elidel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Amlodipine (amlodipine besylate) and Elidel (pimecrolimus). Common drug interactions include eyelid ptosis among females and hepatic enzyme increased among males.
The phase IV clinical study analyzes what interactions people have when they take Amlodipine and Elidel. It is created by eHealthMe based on reports of 110 people who take the same drugs from the FDA, and is updated regularly.
What is Amlodipine?
Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,833 Amlodipine users. Check the latest studies of Amlodipine.
What is Elidel?
Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 5,201 Elidel users. Check the latest studies of Elidel.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
110 people who take Amlodipine and Elidel together, and have interactions are studied.
What are the common drug interactions of Amlodipine and Elidel, by gender? *
What are the common drug interactions of Amlodipine and Elidel, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Amlodipine and Elidel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Amlodipine (354,833 reports)
- Elidel (5,201 reports)
Browse all drug interactions of Amlodipine and Elidel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Amlodipine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Elidel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Amlodipine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Elidel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate and pimecrolimus (the active ingredients of Amlodipine and Elidel, respectively), and Amlodipine and Elidel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cymbalta and Bacterial Infection for Men aged 40-49 - a second ago
- Inflammation and Hypoaesthesia - 2 seconds ago
- Could Triatec cause Inflammation? - 2 seconds ago
- Could Compazine cause Akathisia? - 3 seconds ago
- Could Famotidine cause Joint Effusion? - 5 seconds ago
- Intervertebral Disc Degeneration and Hospitalisation - 6 seconds ago
- Could Neurontin cause Injection Site Nodule? - 6 seconds ago
- Could Famotidine cause Drug Administration Error? - 8 seconds ago
- Could Neurontin cause Dyspnea Paroxysmal Nocturnal? - 10 seconds ago
- Could Neurontin cause Anoxic Encephalopathy? - 17 seconds ago